Search Tag: veteran Mark Velleca

Executive Health Management

2022 04 Feb

StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies has announced the appointment of industry veteran Mark Velleca, M.D., Ph.D. as Chief Executive Officer and a member of its Board of Directors. Mark succeeds Sapan Shah, Ph.D., who is leaving StrideBio to pursue other opportunities after having served as...Read more